Elminda

Elminda, is an inspiring brain-tech company addressing one of the ultimate challenges - understanding the human brain, paving a path for better brain health. In the endless quest for “better health” there are many methods of measuring every part of our bodies. But the brain is one area where real innovation is sorely needed. The inability to accurately measure brain function hinders the management of injuries like concussions, disorders like chronic pain and the discovery for effective therapies for Alzheimer's disease or depression. Importantly, it prevents us from taking ownership of our own brain’s health. Elminda is breaking those barriers with BNA™ (Brain Network Analytics) technology, an electro-physiology based functional brain mapping, imaging and monitoring technology that finally allows medical professionals as well as patients and their families to SEE more, KNOW more and DO more, inspiring a revolutionary path to better brain health and creation of new standards for the assessment and treatment of brain related disorders. Elminda has spent a decade pioneering a fusion of big data analytics, artificial intelligence and brain network analytics mapping that can quantify function and dysfunction, disease progression, and therapeutic effects in cases of neurological and psychiatric disorders such as depression or pain. BNA™ was cleared by the FDA and CE Mark and is available for commercial and clinical use in the US, EU as well as in Israel. Elminda is a revenue stage company with a unique business model combining a medical device and high margin cloud-based Software as a Service (SaaS). The company employs a top team of employees with offices in both Herzeliya and Chicago. The company is widely recognized for its innovative approach to neuroscience, ranking among Fast Company’s annual list of the World's most innovative companies and a World Economic Forum Technology Pioneer.